Pfizer is buying sickle cell drug maker Global Blood Therapeutics in an approximately $5.4 billion deal as it looks to accelerate growth after its revenue soared during the pandemic
Related posts
-
Illinois governor moves to slash cover crop funds despite rising demand
Six years ago, Illinois became the second state in the nation to offer subsidies to farmers... -
Demonstrators protest Trump, Musk in Arlington Heights and other suburbs
Critics of President Donald Trump and adviser Elon Musk took to the streets in Arlington Heights... -
Chicago men accused of trafficking drugs through Lake County
Two Chicago men are facing drug charges following an investigation by a Lake County sheriff’s task...